Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.846
-0.025 (-2.84%)
At close: Apr 24, 2024, 4:00 PM
0.839
-0.007 (-0.82%)
Pre-market: Apr 25, 2024, 8:37 AM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $1.82 billion as of April 25, 2024. Its market cap has decreased by -28.00% in one year.
Market Cap
1.82B
Enterprise Value
1.10B
1-Year Change
-28.00%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since February 24, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.35B to $1.82B, a decrease of -22.40%. That is a compound annual growth rate of -7.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 1.87B | 3.32% |
Apr 22, 2024 | 1.81B | -2.54% |
Apr 19, 2024 | 1.86B | -6.49% |
Apr 18, 2024 | 1.99B | 6.08% |
Apr 17, 2024 | 1.88B | -4.49% |
Apr 16, 2024 | 1.97B | -3.90% |
Apr 15, 2024 | 2.04B | -5.94% |
Apr 12, 2024 | 2.17B | -3.81% |
Apr 11, 2024 | 2.26B | -6.25% |
Apr 10, 2024 | 2.41B | -3.45% |
Apr 9, 2024 | 2.50B | 4.50% |
Apr 8, 2024 | 2.39B | 2.78% |
Apr 5, 2024 | 2.32B | 0.93% |
Apr 4, 2024 | 2.30B | -1.83% |
Apr 3, 2024 | 2.35B | 3.81% |
Apr 2, 2024 | 2.26B | -6.25% |
Apr 1, 2024 | 2.41B | -3.45% |
Mar 28, 2024 | 2.50B | 5.46% |
Mar 27, 2024 | 2.37B | 2.80% |
Mar 26, 2024 | 2.30B | -1.83% |
Mar 25, 2024 | 2.35B | 1.87% |
Mar 22, 2024 | 2.30B | -6.14% |
Mar 21, 2024 | 2.45B | -0.87% |
Mar 20, 2024 | 2.48B | 5.51% |
Mar 19, 2024 | 2.35B | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Owens & Minor | 1.96B |
PTC Therapeutics | 1.95B |
Galapagos NV | 1.94B |
Beam Therapeutics | 1.92B |
NewAmsterdam Pharma Company | 1.91B |
BrightSpring Health Services | 1.83B |
Fusion Pharmaceuticals | 1.82B |
NeoGenomics | 1.81B |